CSPG4 and breast cancer: The prognostic value of high CSPG4 expression has already been reported in melanoma [37], glioblastoma [38], breast cancer [39], head and neck squamous cell carcinomas [40], and hepatocellular carcinoma [41]; however, and by contrast with our result, CSPG4 expression was associated with poor prognosis.